@TimWitneyi
iAccount based inUnited Kingdom
About this account
- Account based in
- United Kingdom
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Professor of Molecular Imaging & @WellcomeTrust SRF @KingsCollegeLon | Biochemist | Developing new methods to detect cancer, therapy response & drug resistance.
London, UK
Joined March 2014
- Tweets4.9K
- Following706
- Followers2.3K
- Likes4.3K
Pinned Tweet
I’m now over at the other place where the ☁️ is 🔵 with the same username. Follow me there.
Tim Witney retweeted
Submission alert: we have opened a new collection on 'Super-resolution Imaging' at #npjImaging @Nature_NPJ!
Tim Witney retweeted
In the Spotlight: Hidden in Plain Sight: Clinical Imaging of the Tumor Microenvironment with PET aacrjournals.org/cancerdisco…
By Timothy Witney @TimWitney @KingsCollegeLon
Voting is now open for (vice)president of the @ESMI_society and closes on 27th February. It's an honour to stand for election. Thank you to all those who chose to vote for me. 🙏
Tim Witney retweeted
With the appointment of the new chief executive of @UKRI_News “imminent”, @MilesPadgett and I explore the key issues s/he will face.
“Eight critical questions for the new chief executive of UKRI” wonkhe.com/blogs/eight-criti… via @wonkhe
Tim Witney retweeted
Seeing the unseen! FAP-PET unlocks TME visualization, allowing the imaging of cancer-associated fibroblasts (CAFs), notably in tumors with low metabolic activity. aacrjournals.org/cancerdisco…
Dear wonderful imaging community,
I'm running for (vice)president of @ESMI_society . A society I care deeply about.
The election opens on 18th February for all members of the society. I would be very grateful for your vote. 🙏
Tim
Tim Witney retweeted
Out at @naturemethods just now!
nature.com/articles/s41592-0…
We present #SN2N, a flagship level unsupervised denoising solution. It’s fully competitive with supervised learning without needing large training-set and clean ground-truth, using 1 noisy frame for training.
(1/n)
Tim Witney retweeted
Research led by @TimWitney from 🇬🇧 @kingsmedicine shows that a new #radiotracer – an injected compound used in #PET scans – could help inform doctors that a patients aggressive #cancer will not respond to #chemotherapy before treatment is given. dlvr.it/TH94TP
Tim Witney retweeted
I wish you all a Merry X-Mas. If you have the time, I invite you to listen to the latest ESMI podcast - Dive into Imaging Science, in which I talk about an exciting paper on how to make tissue transparent in vivo:
e-smi.eu/podcast/
Anyone working on NRF2 activation in cancer? If so, this might be of interest to you.
nature.com/articles/s41467-0…
Tim Witney retweeted
Great to see this collaborative paper out @NatureComms. @TimWitney's team developed a PET radiotracer that distinguishes high/low NRF2 antioxidant pathway activation, including in our @CRUKLungCentre PDX models.
Congrats @hgreenwood93 and team! 👏
nature.com/articles/s41467-0…
Tim Witney retweeted
Scientists have used a chemical compound to light up treatment-resistant cancers on imaging scans.
The breakthrough could help medical professionals better target and treat cancer.
@kingsmedicine
kcl.ac.uk/news/scientists-de…
Tim Witney retweeted
In @Nature_NPJ Imaging. we treated some lucky mice to low, normal, and high-zinc chow—and turns out, their prostates have a lot to say on MRI. Great collaboration effort with @VeronicaClavij8 @ADeanSherry @UTSWMedCenter @uktuebingen @DKFZ @MGHMartinos nature.com/articles/s44303-0…
At npj Imaging we are very excited about radiotheranostics.
🚨 Fellow #radiotheranostics nerds 🚨
Prof. @TimWitney @KingsCollegeLon and I are launching a Collection focused on this very topic for @Nature_NPJ Imaging!
Please considering submitting! Site is live!
#radiopharmaceuticals #nucmed #radonc